Inactive Instrument

News Boston Therapeutics, Inc. Other OTC

Equities

BTHE

US1011501004

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Nanomix Corporation Announces Chief Executive Officer Changes	Nov. 24	CI
Nanomix Announces Equity Investment from Senior Executive of Woodley Equipment Company, Ltd. at a Premium to Market	23-04-13	GL
NANOMIX CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	23-04-07	AQ
Nanomix Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-07	CI
Nanomix Corporation Auditor Raises 'Going Concern' Doubt	23-04-06	CI
NANOMIX CORP : Regulation FD Disclosure (form 8-K)	23-03-10	AQ
NANOMIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-01-25	AQ
Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer	23-01-25	GL
Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer	23-01-25	GL
Nanomix Corporation Appoints Christopher R. Hetterly as Chief Financial Officer	23-01-25	CI
Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy	22-11-29	GL
Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy	22-11-29	GL
Nanomix Corporation Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy	22-11-29	CI
Nanomix Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
NANOMIX CORP : Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	22-11-10	AQ
Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.	22-11-09	GL
Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.	22-11-09	AQ
Nanomix Corporation Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd	22-11-09	CI
Nanomix Corporation announced that it has received $0.069779 million in funding from Woodley Equipment Company Ltd.	22-11-08	CI
Nanomix Enters into Multi-Country Distribution Agreement for the eLab System with Mast Group Limited	22-11-04	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Boston Therapeutics, Inc. Other OTC

Equities

BTHE

US1011501004

Summary

Filters